A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

Novo Nordisk Investigational Site

Birmingham, Alabama, United States, 35222

Novo Nordisk Investigational Site

Montgomery, Alabama, United States, 36106

Novo Nordisk Investigational Site

Concord, California, United States, 94553

Novo Nordisk Investigational Site

Los Angeles, California, United States, 90057

Novo Nordisk Investigational Site

Walnut Creek, California, United States, 94598

Novo Nordisk Investigational Site

Golden, Colorado, United States, 80401

Novo Nordisk Investigational Site

DeLand, Florida, United States, 32720

Novo Nordisk Investigational Site

Jacksonville, Florida, United States, 32216

Novo Nordisk Investigational Site

Orlando, Florida, United States, 32825

Novo Nordisk Investigational Site

Oviedo, Florida, United States, 32765

Novo Nordisk Investigational Site

Conyers, Georgia, United States, 30094

Novo Nordisk Investigational Site

Albany, New York, United States, 12203

Novo Nordisk Investigational Site

Chapel Hill, North Carolina, United States, 27514

Novo Nordisk Investigational Site

Greensboro, North Carolina, United States, 27408

Novo Nordisk Investigational Site

Amarillo, Texas, United States, 79106

Novo Nordisk Investigational Site

Austin, Texas, United States, 78738

Novo Nordisk Investigational Site

Dallas, Texas, United States, 75230

Novo Nordisk Investigational Site

Dallas, Texas, United States, 75390

Novo Nordisk Investigational Site

Houston, Texas, United States, 77079

Novo Nordisk Investigational Site

Longview, Texas, United States, 75605

Novo Nordisk Investigational Site

Sugar Land, Texas, United States, 77479

Novo Nordisk Investigational Site

Richmond, Virginia, United States, 23294

Novo Nordisk Investigational Site

Winchester, Virginia, United States, 22601-3834

Novo Nordisk Investigational Site

Blagoevgrad, Bulgaria, 2700

Novo Nordisk Investigational Site

Burgas, Bulgaria, 8000

Novo Nordisk Investigational Site

Dobrich, Bulgaria, 9300

Novo Nordisk Investigational Site

Pazardzhik, Bulgaria, 4400

Novo Nordisk Investigational Site

Plovdiv, Bulgaria, 4004

Novo Nordisk Investigational Site

Sliven, Bulgaria, 8800

Novo Nordisk Investigational Site

Sofia, Bulgaria, 1233

Novo Nordisk Investigational Site

Stara Zagora, Bulgaria, 6000

Novo Nordisk Investigational Site

Yambol, Bulgaria, 8600

Novo Nordisk Investigational Site

Surrey, British Columbia, Canada, V3Z 2N6

Novo Nordisk Investigational Site

Moncton, New Brunswick, Canada, E1G 1A7

Novo Nordisk Investigational Site

Halifax, Nova Scotia, Canada, B3H 1V7

Novo Nordisk Investigational Site

Hamilton, Ontario, Canada, L8L 5G8

Novo Nordisk Investigational Site

Hamilton, Ontario, Canada, L8M 1K7

Novo Nordisk Investigational Site

London, Ontario, Canada, N5W 6A2

Novo Nordisk Investigational Site

Baja, Hungary, 6500

Novo Nordisk Investigational Site

Budapest, Hungary, 1089

Novo Nordisk Investigational Site

Budapest, Hungary, 1106

Novo Nordisk Investigational Site

Budapest, Hungary, 1132

Novo Nordisk Investigational Site

Debrecen, Hungary, 4025

Novo Nordisk Investigational Site

Nyíregyháza, Hungary, 4405

Novo Nordisk Investigational Site

Székesfehérvár, Hungary, 8000

Novo Nordisk Investigational Site

Lublin, Lubelskie, Poland, 20-044

Novo Nordisk Investigational Site

Lublin, Lubelski, Poland, 20-538

Novo Nordisk Investigational Site

Krakow, Malopolskie, Poland, 31-261

Novo Nordisk Investigational Site

Warsaw, Mazowieckie, Poland, 00-465

Novo Nordisk Investigational Site

Warszawa, Mazowieckie, Poland, 02-507

Novo Nordisk Investigational Site

Bialystok, Podlaskie, Poland, 15-481

Novo Nordisk Investigational Site

Gdynia, Pomorskie, Poland, 81-338

Novo Nordisk Investigational Site

Katowice, Poland, 40-752

Novo Nordisk Investigational Site

Lisboa, Portugal, 1250-230

Novo Nordisk Investigational Site

Lisboa, Portugal, 1349-019

Novo Nordisk Investigational Site

Lisboa, Portugal, 1500-650

Novo Nordisk Investigational Site

Matosinhos, Portugal, 4464-513

Novo Nordisk Investigational Site

Porto, Portugal, 4200-319

Novo Nordisk Investigational Site

Vila Nova de Gaia, Portugal, 4400-346

Novo Nordisk Investigational Site

Bardejov, Slovakia, 08501

Novo Nordisk Investigational Site

Bytca, Slovakia, 014 01

Novo Nordisk Investigational Site

Kosice, Slovakia, 04013

Novo Nordisk Investigational Site

Povazska Bystrica, Slovakia, 01701

Novo Nordisk Investigational Site

Presov, Slovakia, 080 01

Novo Nordisk Investigational Site

Port Elizabeth, Eastern Cape, South Africa, 6001

Novo Nordisk Investigational Site

Bloemfontein, Free State, South Africa, 9301

Novo Nordisk Investigational Site

Johannesburg, Gauteng, South Africa, 1818

Novo Nordisk Investigational Site

Johannesburg, Gauteng, South Africa, 1827

Novo Nordisk Investigational Site

Johannesburg, Gauteng, South Africa, 1829

Novo Nordisk Investigational Site

Johannesburg, Gauteng, South Africa, 2013

Novo Nordisk Investigational Site

Durban, KwaZulu Natal, South Africa, 4093

Novo Nordisk Investigational Site

Durban, KwaZulu-Natal, South Africa, 4001

Novo Nordisk Investigational Site

Durban, KwaZulu-Natal, South Africa, 4092

Novo Nordisk Investigational Site

Umkomaas, KwaZulu-Natal, South Africa, 4170

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 12, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments